Diaverum appoints new CFO and new Chief Strategy & Health Policy Affairs Officer
Martin Loeffler and Dr Claus Biermann join renal care provider
Munich, 21 January 2015 – Diaverum, one of the leading renal care providers worldwide, has appointed two German top managers to join the Executive Team. As of February 1st, Martin E. Loeffler, an internationally experienced finance executive takes on the role of Chief Financial Officer from Annette Kumlien, now SVP, Chief Operating Officer at Diaverum. The Strategic Office function has been expanded by adding Governmental Affairs and Health Economics and is now headed by Dr Claus Biermann, who already worked as Executive Advisor for Diaverum in 2014. Both report directly to Dag Andersson, CEO and President of Diaverum.
Commenting on the new appointments in the Executive Team, Dag Andersson said: “We are continuing to grow and broaden the business to a full integrated renal care model and this is also reflected by the latest additions to our Executive Team.
“Martin Loeffler has a proven record of working in dynamic environments and complex settings while Dr Claus Biermann is true industry expert with broad experience in Strategy, Health Policy and Health Economics. Both have a very strong patient focus and will be crucial in evolving the organisation to become an integrated renal care provider,” Dag Andersson added.
Martin E. Loeffler – internationally experienced CFO
Martin Loeffler started his career in Controlling. He took on the role of Managing Director and Regional CFO at Computer 2000 after the acquisition by Tech Data Corporation. From 2003, he served as CFO in different companies such as Thiel Logistik AG, Gagfah S.A. and agri.capital. Before joining Diaverum he worked as Principal at CFO Solutions in Hamburg. Martin Loeffler holds a German business degree as well as a MBA from the University of Georgia.
“Diaverum demonstrated an impressive development over the last years and is a highly appreciated partner due to its global approach combined with the flexibility to adapt to local requirements. I am very much looking forward to help driving the growth and performance of this business,” said Martin Loeffler, SVP, CFO Diaverum.
Dr Claus Biermann – international health industry expert
“I am excited to work in this fast-growing company and to jointly pave the way towards integrated renal care. Key success factors will be to develop a healthcare policy monitor, identify and maintain strategic partnerships and implement pilot projects demonstrating the value in integrated healthcare,” said Dr Claus Biermann, SVP, Chief Strategy & Health Policy Affairs Officer at Diaverum.
Prior to joining Diaverum in 2015, Dr Claus W. Biermann worked as Global Executive Healthcare Advisor and Entrepreneur. He started his career in 1990 in different medical, quality and research functions at the University Hospitals Hamburg, Bochum, Muenster, Aarhus and Chicago, before he worked in different healthcare top management positions at Janssen-Cilag Germany/Europe, Gruenenthal, Coss AG and T-System International. In 2006 he joined Royal Philips Electronics as Vice President Global Business Development Healthcare and Chief Medical Officer Emerging Markets Healthcare. In 2012 he took on the role of Executive Director Market Development & Innovation Healthcare at GE Germany/Europe. He studied medical studies in Switzerland, Germany and the USA. Being a doctor of medicine (MD) he holds a Master of Public Health (MPH) from the University of Bielefeld, Germany.
The full Diaverum Executive Team can be found at www.diaverum.com/Executive-Team
Press Contact
Ulrike Beringer
Corporate Communications Diaverum
E-mail: Ulrike.Beringer@diaverum.com
Phone: + 49 / 89 45 2444 124
About Diaverum
Diaverum is a global integrated renal care provider with a clear patient focus. As one of the world’s leading renal care providers we stand for excellent medical quality, renal care services and a patient-centred research. Being product-independent also gives us the flexibility to offer individual treatments for the individual needs of our patients and by coordinating our patients’ healthcare needs, we are improving their quality of life. At the same time we are creating value in the healthcare system by optimising the use of healthcare budgets — for the benefit of the patient and the society. Our experience in renal care dates back more than 20 years, when the first dialysis clinic was established, under the former name Gambro Healthcare, defining our Swedish roots. Today 8,500 employees care for more than 26,000 patients in 19 countries in Europe, Latin America, Middle East and Australia. The corporate office is located in Munich, Germany. www.diaverum.com
Tags:
